G2G Consulting Provides Updates from Washington D.C.
G2G Consulting Provides Updates from Washington D.C. […]
G2G Consulting Provides Updates from Washington D.C. […]
bioMérieux Recognized as Top 1% by S&P Global […]
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) […]
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership […]
The 2025 Wilson Sonsini E&I Summit Attracts Over 400 Participants […]
Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants […]
iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia […]
As part of BioHive week, Altitude Lab hosted its annual Demo Day. […]
Pacelli, A Former Executive of Dexcom, Inc., Will Lead Epitel Into Its Next Phase of Growth […]
Sera Prognostics Announces Pricing of $50 Million Public Offering […]
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to recapture the heights of old. […]